✦ LIBER ✦

PMH40 COST-EFFECTIVENESS OF RITALINTM VERSUS ADDERALLTM FOR FIRST-LINE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN

✍ Scribed by S Narayan; JW Hay

Book ID: 119593152
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 62 KB
Volume: 7
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)62235-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH9 COST-EFFECTIVENESS OF CLINICALLY PR

PMH9 COST-EFFECTIVENESS OF CLINICALLY PROVEN TREATMENT STRATEGIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN FIVE JURISDICTIONS

✍ M Schlander; O Schwarz; L Hakkaart-van Roijen; PS Jensen; U Persson; PJ Santosh; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PMH1 COST-EFFECTIVENESS OF CLINICALLY PR

PMH1 COST-EFFECTIVENESS OF CLINICALLY PROVEN TREATMENT STRATEGIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): IMPACT OF COEXISTING CONDITIONS

✍ M Schlander; O Schwarz; EM Foster; L Hakkaart-van Roijen; PS Jensen; U Persson; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMH37 THE COST-EFFECTIVENESS OF GUANFACI

PMH37 THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS

✍ Erder, M.; Chen, K.; Wu, E.Q.; Hodgkins, P.; Sikirica, V. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Cost Effectiveness of Guanfacine Extende

Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder

✍ Erder, M. Haim; Xie, Jipan; Signorovitch, James E.; Chen, Kristina S.; Hodgkins, 📂 Article 📅 2012 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 208 KB

PIH29 the Cost Effectiveness of Clinical

PIH29 the Cost Effectiveness of Clinically Proven Treatment Strategies for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adult Patients

✍ M. Schlander; A. Philipsen; O. Schwarz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMH36 A COST-UTILTY ANALYSIS OF ATOMOXET

PMH36 A COST-UTILTY ANALYSIS OF ATOMOXETINE AGAINST CURRENT STIMULANT THERAPIES FOR THE TREATMENT OF CHILDREN WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN GERMANY

✍ A Diamantopoulos; M Lorenzo; M Happich; S Cottrell; H Scheijbeler 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB